WCO-IOF: Rituximab positively impacts QOL in patients with rheumatoid arthritis
Effect of rituximab therapy on life quality with rheumatoid arthritis patients
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
98 patients diagnosed with rheumatoid arthritis (RA) were randomized to receive methotrexate with or without rituximab therapy to determine effect of rituximab on quality of life in this patient population. The Euro-QOL 5 dimension (EQ-5D) and Health Assessment Questionnaire for Rheumatoid Arthritis (HAQ) were assessed over 24 months. Upon analysis, combined methotrexate and rituximab therapy achi...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE